Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC1544446555;46556;46557 chr2:178620087;178620086;178620085chr2:179484814;179484813;179484812
N2AB1380341632;41633;41634 chr2:178620087;178620086;178620085chr2:179484814;179484813;179484812
N2A1287638851;38852;38853 chr2:178620087;178620086;178620085chr2:179484814;179484813;179484812
N2B637919360;19361;19362 chr2:178620087;178620086;178620085chr2:179484814;179484813;179484812
Novex-1650419735;19736;19737 chr2:178620087;178620086;178620085chr2:179484814;179484813;179484812
Novex-2657119936;19937;19938 chr2:178620087;178620086;178620085chr2:179484814;179484813;179484812
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: I
  • RefSeq wild type transcript codon: ATA
  • RefSeq wild type template codon: TAT
  • Domain: Ig-106
  • Domain position: 54
  • Structural Position: 135
  • Q(SASA): 0.2074
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
I/V rs1333036641 -1.227 None N 0.109 0.126 0.310458034454 gnomAD-2.1.1 4.07E-06 None None None None N None 0 0 None 0 5.64E-05 None 0 None 0 0 0
I/V rs1333036641 -1.227 None N 0.109 0.126 0.310458034454 gnomAD-4.0.0 1.59876E-06 None None None None N None 0 0 None 0 2.78583E-05 None 0 0 0 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
I/A 0.1971 likely_benign 0.3711 ambiguous -1.718 Destabilizing 0.007 N 0.329 neutral None None None None N
I/C 0.4637 ambiguous 0.627 pathogenic -0.945 Destabilizing 0.356 N 0.493 neutral None None None None N
I/D 0.4714 ambiguous 0.6864 pathogenic -1.738 Destabilizing 0.072 N 0.624 neutral None None None None N
I/E 0.3152 likely_benign 0.5045 ambiguous -1.771 Destabilizing 0.072 N 0.618 neutral None None None None N
I/F 0.1272 likely_benign 0.1593 benign -1.436 Destabilizing None N 0.154 neutral None None None None N
I/G 0.4318 ambiguous 0.6643 pathogenic -2.007 Highly Destabilizing 0.072 N 0.581 neutral None None None None N
I/H 0.2439 likely_benign 0.3641 ambiguous -1.279 Destabilizing 0.628 D 0.589 neutral None None None None N
I/K 0.1838 likely_benign 0.2795 benign -1.088 Destabilizing 0.055 N 0.617 neutral N 0.444137673 None None N
I/L 0.0875 likely_benign 0.1108 benign -0.996 Destabilizing None N 0.104 neutral N 0.476297567 None None N
I/M 0.0971 likely_benign 0.121 benign -0.62 Destabilizing None N 0.155 neutral N 0.477222226 None None N
I/N 0.1466 likely_benign 0.2394 benign -0.866 Destabilizing 0.072 N 0.625 neutral None None None None N
I/P 0.8836 likely_pathogenic 0.956 pathogenic -1.207 Destabilizing 0.136 N 0.64 neutral None None None None N
I/Q 0.2076 likely_benign 0.3412 ambiguous -1.156 Destabilizing 0.356 N 0.626 neutral None None None None N
I/R 0.1588 likely_benign 0.2264 benign -0.428 Destabilizing 0.055 N 0.629 neutral N 0.473016192 None None N
I/S 0.156 likely_benign 0.2757 benign -1.372 Destabilizing 0.016 N 0.497 neutral None None None None N
I/T 0.1012 likely_benign 0.1721 benign -1.304 Destabilizing None N 0.146 neutral N 0.436969089 None None N
I/V 0.0792 likely_benign 0.0771 benign -1.207 Destabilizing None N 0.109 neutral N 0.416283759 None None N
I/W 0.5506 ambiguous 0.6953 pathogenic -1.505 Destabilizing 0.864 D 0.573 neutral None None None None N
I/Y 0.302 likely_benign 0.404 ambiguous -1.279 Destabilizing 0.038 N 0.542 neutral None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.